Andrzej Jakubowiak to France
This is a "connection" page, showing publications Andrzej Jakubowiak has written about France.
Connection Strength
0.033
-
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study. Lancet Haematol. 2015 Dec; 2(12):e516-27.
Score: 0.033